ISRCTN46268487已完成未知
A randomised, double blind, placebo-controlled study of the effects of Dehydroepiandrosterone (DHEA) replacement on vascular function in patients with primary and secondary adrenal insufficiency
Cardiff University (UK)0 个研究点目标入组 40 人开始时间: 2005年6月10日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
2009 results on http://www.ncbi.nlm.nih.gov/pubmed/19318448
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Individuals with at least a 4 year history of primary adrenal insufficiency and those with secondary adrenal insufficiency as a result of pituitary surgery for a non-functioning pituitary tumour who did not receive radiotherapy and who are on stable doses of full hormone replacement including growth hormone.
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
2 期
A randomised, double blind, placebo-controlled, phase 2a study of the efficacy, safety and pharmacokinetics of MLN3897 in patients with rheumatoid arthritis taking methotrexateRheumatoid arthritisISRCTN49455679Academic Medical Center (AMC) (The Netherlands)191
已完成
2 期
A phase II/III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without thalidomide in advanced Non-Small Cell Lung Cancer (NSCLC)on-small cell lung cancerMalignant neoplasm of lungCancerISRCTN77341241Sponsor not defined - Record supplied by London Lung Cancer Group722
已完成
不适用
A multicentre, double blind, placebo controlled, randomised trial to evaluate the effectiveness of a one-day versus seven-day regimen of nitrofurantoin for the treatment of asymptomatic bacteriuria in pregnancyAsymptomatic Bacteriuria (ASB)Infections and InfestationsBacteriuriaISRCTN11966080World Health Organization (WHO) (Switzerland)778
已完成
不适用
Studying the impact of Lorazepam on approach/avoidance behaviour in healthy individualsISRCTN12590498Psychiatric University Hospital (Psychiatrische Universitätsklinik) Zürich (PUK ZH)60
已完成
3 期
A phase III randomised, double blind, placebo controlled trial of carboplatin/etoposide with or without thalidomide in small cell lung cancerSmall cell lung cancerMalignant neoplasm of bronchus or lungCancerISRCTN16174527Sponsor not defined - Record supplied by London Lung Cancer Group724